钙拮抗剂TMB-8抑制BHQ,NE和KCl引起的培养乳牛基底动脉单个平滑肌细胞内游离钙的升高

用ＡＲＣＭＭＩＣ阳离子测定系统，测量单个细胞内游离钙浓度（［Ｃａ２＋］ｉ），研究８（Ｎ，Ｎ二乙胺）ｎ辛基３，４，５三甲氧基苯甲酸酯（ＴＭＢ８）对培养乳牛基底动脉平滑肌［Ｃａ２＋］ｉ的作用。在细胞外钙浓度为１３ｍｍｏｌ·Ｌ－１时，ＴＭＢ８（３０μｍｏｌ·Ｌ－１）可明显抑制ＢＨＱ，ＮＥ及ＫＣｌ引起［Ｃａ２＋］ｉ的升高。在细胞外钙为零＋ＥＧＴＡ０１ｍｍｏｌ·Ｌ－１时，ＴＭＢ８（１０，３０及１００μｍｏｌ·Ｌ－１）可浓度依赖性地降低静息［Ｃａ２＋］ｉ，ＴＭＢ８（３０μｍｏｌ·Ｌ－１）可几乎完全阻断ＢＨＱ及ＮＥ引起［Ｃａ２＋］ｉ的增加。研究表明ＴＭＢ８降低培养乳牛基底动脉平滑肌［Ｃａ２＋］ｉ的机制，主要是抑制肌浆网Ｃａ２＋的释放，或增加肌浆网对Ｃａ２＋的摄入，并由此间接地抑制细胞外钙的内流。     

钙拮抗剂TMB-8对培养牛大脑中动脉内皮细胞[Ca2+]i和一氧化氮释放的影响

目的旨在观察TMB-8对血管内皮细胞[Ca²⁺]i水平和NO释放的影响,探讨扩张脑血管的机制。用AR-CM-MIC阳离子测定系统,测量单个细胞内游离钙浓度([Ca²⁺]i),用血红蛋白法测量一氧化氮(NO)的释放。结果表明,在细胞外钙浓度为1.3mmol·L^-1时,TMB-8 12.5及25.0μmol·L^-1对静息[Ca²⁺]i和甲基血红蛋白ΔE无明显影响,而50及100μmol·L^-1时可升高静息[Ca²⁺]i和甲基血红蛋白ΔE。表明TMB-850及100μmol·L^-1升高脑血管内皮[Ca²⁺]i,激活NO合酶,促进NO合成和释放,这可能是其扩张脑血管的重要机制之一。     

钙拮抗剂TMB-8对培养牛大脑中动脉内皮细胞[Ca2+]i和一氧化氮释放的影响

目的旨在观察ＴＭＢ８对血管内皮细胞［Ｃａ２＋］ｉ水平和ＮＯ释放的影响，探讨扩张脑血管的机制。用ＡＲＣＭＭＩＣ阳离子测定系统，测量单个细胞内游离钙浓度（［Ｃａ２＋］ｉ），用血红蛋白法测量一氧化氮（ＮＯ）的释放。结果表明，在细胞外钙浓度为１３ｍｍｏｌ·Ｌ－１时，ＴＭＢ８１２５及２５０μｍｏｌ·Ｌ－１对静息［Ｃａ２＋］ｉ和甲基血红蛋白ΔＥ无明显影响，而５０及１００μｍｏｌ·Ｌ－１时可升高静息［Ｃａ２＋］ｉ和甲基血红蛋白ΔＥ。表明ＴＭＢ８５０及１００μｍｏｌ·Ｌ－１升高脑血管内皮［Ｃａ２＋］ｉ，激活ＮＯ合酶，促进ＮＯ合成和释放，这可能是其扩张脑血管的重要机制之一。     

TMB-8抑制5-HT和KCl引起大鼠脑血流量减少

目的研究TMB-8对5-HT和KCl引起的大鼠脑血流量(CBF)减少的作用。方法用激光多普勒血流仪测量大鼠CBF,在人工脑脊液灌流液中加入TMB-8和工具药进行干预。结果12.5, 25和50 μmol·L^-1 TMB-8对大鼠CBF无明显影响,TMB-8可抑制5-HT引起的大鼠CBF减少。在1 μmol·L^-1 5-HT引起大鼠CBF持续下降的状态下,TMB-8可浓度依赖的增加大鼠CBF。TMB-8也可抑制KCl引起的大鼠CBF减少。在20 mmol·L^-1 KCl引起大鼠CBF持续下降的状态下,TMB-8可浓度依赖的增加大鼠CBF。结论TMB-8可抑制5-HT和KCl引起的大鼠CBF减少,也可浓度依赖的增加被5-HT和KCl所减少的大鼠CBF,改善大鼠缺血区脑血供。     

TMB-8对去甲肾上腺素和BHQ引起新生大鼠单个脑细胞内游离钙增高的影响

应用AR-CM-MIC阳离子测定系统,研究TMB-8对体外新生SD大鼠单个脑细胞内游离钙的抑制作用及其机制。结果表明,在无细胞外钙情况下,静息[Ca²⁺]i为79±13nmol·L^-1。TMB-810,30μmol·L^-1能明显降低静息[Ca²⁺]i。TMB-8100μmol·L^-1对高钾去极化引起的[Ca²⁺]i显著增高无明显影响。在细胞外钙为1.3mmol·L^-1时,去甲肾上腺素诱导的细胞内[Ca²⁺]i升高可部分被TMB-8抑制;TMB-8(30μmol·L^-1)对BHQ引起的[Ca²⁺]i的升高无明显抑制作用。而当细胞外液[Ca²⁺]i为0时,TMB-8几乎完全抑制了去甲肾上腺素和BHQ的作用。提示TMB-8降低脑细胞内游离钙的作用机制是通过促使细胞内钙进入肌浆网以抑制内钙的释放,并通过饱和肌浆网内Ca²⁺间接地阻滞细胞膜钙通道。     

TMB—8抑制组胺,5—羟色胺和谷氨酸引起的培养乳牛基底动脉平滑肌细 …

AIM: To study the effects of 8-(N,N-diethylamino)-n-octyl-3,4,5- trimethoxybenzoate (TMB-8) on intracellular free calcium ([Ca2+]i) in cultured calf basilar artery smooth muscle cells. METHODS: [Ca2+]i was examined by a system of measurement of AR-CM-MIC, using Fura 2-AM as a fluorescent indicator. RESULTS: In the presence of extracellular Ca2+ 1.3 mmol.L-1, histamine (His), serotonin (5-HT), and sodium glutamate (Glu) markedly increased the [Ca2+]i which was attenuated by TMB-8. In Ca2+ free Hanks' solution containing egtazic acid 0.1 mmol.L-1, TMB-8 not only reduced the resting [Ca2+]i, but also inhibited the elevation of [Ca2+]i evoked by His and 5-HT. CONCLUSION: TMB-8 reduced the resting [Ca2+]i and attenuated His-, 5-HT-, and Glu-induced increases of [Ca2+]i in basilar artery smooth muscle cells.     

Dopamine D(2) receptor-induced COX-2-mediated production of prostaglandin E(2) in D(2)-transfected Chinese hamster ovary cells without simultaneous administration of a Ca(2+)-mobilizing agent

We have earlier demonstrated that dopamine stimulates the liberation of the prostaglandin E(2) (PGE(2)) precursor, arachidonic acid, in Chinese hamster ovary cells transfected with the rat dopamine D(2) receptor (long isoform), also without concomitant administration of a Ca(2+)-releasing agent [Nilsson et al., Br J Pharmacol 1998;124:1651-8]. In the present report, we show that dopamine, under the same conditions, also induces a concentration-dependent increase in the production of PGE(2), with a maximal effect of 235% at approximately 100 microM, and with an EC(50) of 794 nM. The effect was counteracted by the D(2) antagonist eticlopride, pertussis toxin, the inhibitor of intracellular Ca(2+) release TMB-8, incubation in Ca(2+)-free experimental medium, and PKC desensitization obtained by chronic pretreatment with the phorbol ester TPA. It was also antagonized by the non-specific cyclooxygenase (COX) inhibitor, indomethacin, and by the selective COX-2 inhibitor, NS-398, but not by the specific COX-1 inhibitor, valeryl salicylate. Both the non-specific phospholipase A(2) inhibitor, quinacrine, and an inhibitor of cPLA(2) and iPLA(2), AACOF3, counteracted the effect; in contrast, a selective iPLA(2) inhibitor, BEL, and a selective sPLA(2) inhibitor, TAPC, were ineffective. No effects of dopamine were obtained in control cells mock-transfected with the p3C vector only. The results reinforce previous assumptions that dopamine may interact with eicosanoid metabolism by means of D(2) receptor activation, and implicate an involvement of cPLA(2) and COX-2 in this effect. It is suggested that measurement of dopamine-induced PGE(2) production may serve as a convenient way to study D(2) receptor function in vitro.